Uveitis Completed Phase 1 / 2 Trials for Ranibizumab (DB01270)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00498355Lucentis for Inflammatory Macular Edema TrialTreatment